Polymorphisms of cholesterol 24-hydroxylase (CYP46A1) gene were protective against Alzheimer's disease in Chinese population

被引：0
|
作者：
Ling, S [1 ]
机构：
[1] Chinese Univ Hong Kong, Fac Med, Dept Psychiat, Shatin, Hong Kong, Peoples R China
来源：
INTERNATIONAL PSYCHOGERIATRICS | 2005年 / 17卷
关键词：
D O I：
暂无
中图分类号：
B849 [应用心理学];
学科分类号：
040203 ;
摘要：
引用
收藏
页码：3 / 4
页数：2
相关论文
共 50 条
  • [41] Association analysis between Alzheimer's disease and the CYP46 gene polymorphisms
    Macé, S
    NEUROBIOLOGY OF AGING, 2004, 25 : S485 - S485
  • [42] LincRNA Plays a Role in the Effect of CYP46A1 Polymorphism in Alzheimer's Disease - Related Pathology
    Chen, Yang
    Li, Hui-Yun
    Zeng, Fan
    Chen, Le
    Zhou, Fa-Ying
    Peng, Ze-Yan
    Yang, Hai
    Zhou, Hua-Dong
    Wang, Yan-Jiang
    Li, Ling
    FRONTIERS IN AGING NEUROSCIENCE, 2020, 11
  • [43] Role of Cholesterol Metabolic Enzyme CYP46A1 and Its Metabolite 24S-Hydroxycholesterol in Ischemic Stroke
    Sun, Huawei
    Yang, Tao
    Simon, Roger P.
    Xiong, Zhi-gang
    Leng, Tiandong
    STROKE, 2024, 55 (10) : 2492 - 2501
  • [44] AAV-Mediated CYP46A1 Gene Therapy as a Strategy to Counteract Huntington's Disease
    Cartier, Nathalie
    Alves, Sandro
    Christaller, Wilhelm
    Subashi, Enedja
    Kacher, Radia
    Lamaziere, Antonin
    Despres, Gaetan
    Piguet, Francoise
    Saudou, Frederic
    Caboche, Jocelyne
    Betuing, Sandrine
    MOLECULAR THERAPY, 2018, 26 (05) : 308 - 309
  • [45] Association between a T/C polymorphism in intron 2 of cholesterol 24S-hydroxylase gene and Alzheimer's disease in Chinese
    Wang, BB
    Zhang, CF
    Zheng, WD
    Lu, ZP
    Zheng, CG
    Yang, Z
    Wang, L
    Jin, F
    NEUROSCIENCE LETTERS, 2004, 369 (02) : 104 - 107
  • [46] Genetic variation of the cholesterol 24-hydroxylase (CYP46) gene in patients with age-related macular degeneration or primary open-angle glaucoma
    Bretillon, L
    Bron, AM
    Acar, N
    Joffre, C
    Arnavielle, S
    Creuzot-Garcher, C
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46
  • [47] Variants of CYP46A1 may interact with age and APOE to influence CSF Aβ42 levels in Alzheimer’s disease
    Annica Johansson
    Hagit Katzov
    Henrik Zetterberg
    Lars Feuk
    Boo Johansson
    Nenad Bogdanovic
    Niels Andreasen
    Boris Lenhard
    Anthony J. Brookes
    Nancy L. Pedersen
    Kaj Blennow
    Jonathan A. Prince
    Human Genetics, 2004, 114 : 581 - 587
  • [48] Variants of CYP46A1 may interact with age and APOE to influence CSF Aβ42 levels in Alzheimer's disease
    Johansson, A
    Katzov, H
    Zetterberg, H
    Feuk, L
    Johansson, B
    Bogdanovic, N
    Andreasen, N
    Lenhard, B
    Brookes, AJ
    Pedersen, NL
    Blennow, K
    Prince, JA
    HUMAN GENETICS, 2004, 114 (06) : 581 - 587
  • [49] Association of cholesterol 7α-hydroxylase (CYP7A1) promoter polymorphism (rs3808607) and cholesterol 24S-hydroxylase (CYP46A1) intron 2 polymorphism (rs754203) with serum lipids, vitamin D levels, and multiple sclerosis risk in the Turkish population
    Eda Sezer
    Birsen Can Demirdöğen
    Şeref Demirkaya
    Giray Bulut
    Merve Akkulak
    Emre Evin
    Orhan Adalı
    Neurological Sciences, 2022, 43 : 2611 - 2620
  • [50] AAV-mediated CYP46A1 delivery is beneficial in Alzheimer's disease models: towards a clinical application
    Alves, S.
    Michaelsen-Preusse, K.
    Audrain, M.
    Aron-Badin, R.
    Lamaziere, A.
    Fol, R.
    Braudeau, J.
    Despres, G.
    Fouquet, F.
    Pradier, L.
    Delatour, B.
    Korte, M.
    Hantraye, P.
    Aubourg, P.
    Cartier, N.
    HUMAN GENE THERAPY, 2016, 27 (11) : A47 - A47
12345